Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers

被引:22
|
作者
Chuang, Shu-Chun
Hashibe, Mia
Yu, Guo-Pei
Le, Anh D.
Cao, Wei
Hurwitz, Eric L.
Rao, Jian-Yu
Neugut, Alfred I.
Zhang, Zuo-Feng
机构
[1] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[3] Int Agcy Res Canc, Lyon, France
[4] New York Eye & Ear Infirm, Dept Otolaryngol, Biostat & Epidemiol Serv, New York, NY 10003 USA
[5] Univ So Calif, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[7] Columbia Univ Coll Phys & Surg, Dept Med & Epidemiol, New York, NY 10032 USA
关键词
thyroid cancer; second cancer; radiation therapy;
D O I
10.1016/j.canlet.2005.06.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although radiation is considered a risk factor for thyroid cancer, the potential relationship between radiation therapy and the risk of second primary cancer among patients with first primary thyroid cancer has not been evaluated. We identified 26,639 patients with first primary thyroid cancer in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2000. Information on radiation therapy as well as second primary cancers was recorded in SEER. The proportional hazards model was utilized to estimate adjusted risk ratios (RRs) and their 95% confidence intervals (CIs) to assess the potential association between radiation therapy for thyroid cancer and the risk of second primary cancers. With 270,674.33 person-years of follow-up, 1,896 (7.1%) of the 26,639 patients with first primary thyroid cancer developed second primary cancers. Among the second primaries, 35 occurred in the thyroid. No obvious association was observed between radiation therapy and the overall risk of second primary cancer after ten years of follow-up (RR = 1.07, 95% CI = 0.88-1.30). However, an increased risk was seen for several cancers, including upper digestive system cancers (RR = 1.66, 95% CI = 1.07-2.57) and myeloid malignancies (RR=3.26, 95% CI= 1.39-7.67). Radiation therapy was associated with reduced second cancer risks for thyroid cancer (RR = 0.18, 95% CI = 0.04-0.76). Beam radiation might be important to the digestive system, radioactive implants might be associated with the male genital system, radioisotopes might have an effect on myeloid malignancies, and combined beam radiation with radioactive implants or radioisotopes might be related to the increased risk of respiratory system cancers. This study suggests that radiation therapy for patients with first primary thyroid cancer might be associated with an increased risk of developing a second primary cancer in the upper digestive system and second primary myeloid malignancies. Radiation therapy for adult patients with thyroid cancer might be associated with a reduced risk of second primary thyroid cancer. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:42 / 52
页数:11
相关论文
共 50 条
  • [21] Second primary cancers following radiotherapy for prostate cancer: How many are actually due to the radiotherapy?
    Morgan, Scott C.
    Corkum, Mark T.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2024, 18 (04): : 129 - 130
  • [22] Risk of second primary malignancies in women with papillary thyroid cancer
    Canchola, AJ
    Horn-Ross, PL
    Purdie, DM
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (06) : 521 - 527
  • [23] Is smoking a risk factor for second primary lung cancer
    Aredo, Jacqueline, V
    Luo, Sophia J.
    Gardner, Rebecca
    Hickey, Thomas P.
    Riley, Thomas L.
    Wilkens, Lynne R.
    Le Marchand, Loic
    Amos, Christopher, I
    Hung, Rayjean J.
    Johansson, Mattias
    Cheng, Iona
    Wakelee, Heather A.
    Han, Summer S.
    CANCER RESEARCH, 2020, 80 (16)
  • [24] External beam radiotherapy for laryngeal cancer and risk for second primary thyroid carcinoma: A SEER database analysis
    Ahn, P. H.
    Kalnicki, S.
    Garg, M. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Sexual disparity and the risk of second primary thyroid cancer: a paradox
    Hussein, Mohammad
    Mueller, Lauren
    Issa, Peter P.
    Haidari, Muhib
    Trinh, Lily
    Toraih, Eman
    Kandil, Emad
    GLAND SURGERY, 2023, 12 (04) : 432 - 441
  • [26] Second primary cancers in thyroid cancer patients:: A multinational record linkage study
    Sandeep, TC
    Strachan, MWJ
    Reynolds, RM
    Brewster, DH
    Scélo, G
    Pukkala, E
    Hemminki, K
    Anderson, A
    Tracey, E
    Friis, S
    McBride, ML
    Kee-Seng, C
    Pompe-Kirn, V
    Kliewer, EV
    Tonita, JM
    Jonasson, JG
    Martos, C
    Boffetta, P
    Brennan, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (05): : 1819 - 1825
  • [27] Differentiated Thyroid Cancers with Synchronous Second Primary Cancers: Case Series
    Jebin Aaron, Devarajan
    Rathod, Priyank
    Mehta, Shailee
    Pawar, Ajinkya
    Nasir, Imran
    Chowdhury, Anish
    Kapur, Kanika
    Sharma, Mohit
    Puj, Ketul
    Warikoo, Vikas
    Patel, Shailesh
    Patel, Keval
    Salunke, Abhijeet
    Trivedi, Priti
    Bande, Vivek
    Thottiyen, Salahudheen
    Trivedi, Sonal
    Patel, Nikunj
    Joshi, Gautami
    Pandya, Shashank
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, : 3807 - 3814
  • [28] Risk of second primary cancers after treatment for locoregional rectal cancer
    Nangia, Chaitali Singh
    Taylor, Thomas H.
    Tsang, Walter
    Wong, Jason
    Carmichael, Joseph
    Karnes, William
    Zell, Jason A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Nonmelanoma Skin Cancer and the Risk of Second Primary Cancers: a Systematic Review
    Wheless, Lee
    Black, Joshua
    Alberg, Anthony J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (07) : 1686 - 1695
  • [30] The risk of second primary cancers in clear cell and papillary renal cancer
    Hamid, Muhammad Saad
    Shameem, Raji
    Jain, Rishi
    Sullivan, Kevin M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)